WHO and an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Bharat Biotech's Covid vaccine Covaxin, the World Health Organization informed on Tuesday.

Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling basis and submitted additional info at the UN Public Health Agency’s request on September 27.

Experts are currently reviewing this information and if it addresses all questions raised, WHO assessment will be finalized next week, the health agency said.

The Strategic Advisory Group of Experts on Immunization (SAGE) of the WHO met on Tuesday to make its recommendations on Covaxin on EUL, among other issues.